Genipin
Genipin
Genipin（Aladdin G101204 98% high purity; G425537 10mM in DMSO） is a naturally occurring iridoid compound obtained primarily from the fruit of Gardenia jasminoides Ellis, which belongs to the genus Gardenia in the Rubiaceae family. In the plant, genipin exists mainly in the form of geniposide, a glycoside. When geniposide is hydrolyzed (via enzymatic action or acidic conditions), the sugar moiety is removed, yielding genipin. In industry and research, it’s valued for its natural crosslinking properties and low toxicity compared to synthetic crosslinkers like glutaraldehyde.
Genipin was first identified for its ability to cross-link proteins, but it has since been recognized as an inhibitor of uncoupling protein 2 (UCP2)—a mitochondrial carrier protein that suppresses glucose-stimulated insulin secretion. Elevated expression of UCP2 results in reduced insulin release, a process believed to play a role in the onset of type 2 diabetes mellitus.
Beyond its role in metabolic regulation, genipin exhibits a wide range of biological activities, notably its neuroprotective properties. It has been shown to shield hippocampal neurons from amyloid-β-induced toxicity. Aggregation of amyloid-β oligomers is a hallmark of Alzheimer’s disease and is highly neurotoxic. Genipin also counteracts cell damage caused by calcimycin through mechanisms involving endoplasmic reticulum stress. These protective actions suggest that genipin could have potential in slowing or preventing neurodegeneration associated with Alzheimer’s disease and Parkinson’s disease, both of which are linked to oxidative stress.
Genipin further demonstrates other notable neurological effects. It possesses antidepressant activity comparable to that of Fluoxetine Hydrochloride (Aladdin F131623 98% high purity), a well-known serotonin reuptake inhibitor. In animal behavioral models such as the forced swim test and tail suspension test, genipin improves outcomes—likely through its ability to elevate serotonin and norepinephrine levels.
While genipin’s protein cross-linking capability has been extensively characterized, recent research has expanded its potential applications. Proteins cross-linked with genipin are currently being explored in studies aimed at improving drug delivery systems, enhancing cell differentiation, and developing scaffolds for tissue engineering.
References:
1. Chan CB, De Leo D, Joseph JW, et al. Diabetes. 2001 Jun;50(6):1302-10.
2. Sesti G, Cardellini M, Marini MA, et al. Diabetes. 2003 May;52(5):1280-3.
3. Yamazaki M, Sakura N, Chiba K, et al. Biol Pharm Bull. 2001 Dec;24(12):1454-5.
4. Yamazaki M, Chiba K, Yoshikawa C. Biol Pharm Bull. 2009 Jun;32(6):1043-6.
5. Tian JS, Cui YL, Hu LM, et al. Neurosci Lett. 2010 Aug 2;479(3):236-9.
6. Xu J, Strandman S, Zhu JX, et al. Biomaterials. 2015 Jan;37:395-404.
7. Kwon YS, Lim ES, Kim HM, et al. J Endod. 2015 Apr;41(4):501-7.
8. Tambe N, Di J, Zhang Z, et al. J Biomed Mater Res B Appl Biomater. 2015 Aug;103(6):1188-9
Aladdin: https://www.aladdinsci.com/